HER-targeted tyrosine-kinase inhibitors.

Abstract:

:Improved understanding of tumor biology has led to the identification of numerous growth factors that are involved in malignant transformation and tumor progression. Many of these factors induce cellular responses through receptors with intrinsic tyrosine kinase (TK) activity. Therefore, inhibiting receptor TK activity is a way to effectively block the tumorigenic effects that arise from these pathways. The HER family of TK receptors is overexpressed or dysregulated in many types of human cancer. As a result these receptors were identified as targets for cancer therapy. Several agents have been developed that reversibly, or irreversibly, inhibit one, two or all of the HER receptors. Tarceva and Iressa are HER1-TK inhibitors that are advanced in development. Clinical data show that these agents as monotherapy have antitumor activity in patients with various types of solid tumor and are well tolerated; encouraging data are also produced when Tarceva or Iressa are combined with chemotherapeutic agents. Other dual or pan-HER, reversible or irreversible, TK inhibitors are being investigated in phase I trials. Early data show that they are generally well tolerated and have provided evidence of antitumor activity. HER-TK inhibitors are exciting agents that are likely to have a substantial impact on the way we treat patients with cancer.

journal_name

Oncology

journal_title

Oncology

authors

Baselga J,Hammond LA

doi

10.1159/000066198

subject

Has Abstract

pub_date

2002-01-01 00:00:00

pages

6-16

eissn

0030-2414

issn

1423-0232

pii

66198

journal_volume

63 Suppl 1

pub_type

杂志文章,评审

相关文献

ONCOLOGY文献大全
  • Systemic effects of methylcholanthrene in mice. I. Splenic and hepatic phagocytosis of xenogeneic red cells.

    abstract::Male and female mice of strains C3H/eB and C57BL/6 were injected subcutaneously with methylcholanthrene (MCA) dissolved in olive oil; mice injected with olive oil served as controls. After intervals of from 2 to 13 weeks, experimental and control mice were injected intraperitoneally with 51Cr-labeled rat red cells (RR...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225871

    authors: Schrieber R,Stern K

    更新日期:1984-01-01 00:00:00

  • A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases.

    abstract:OBJECTIVE:The purpose of this study was to establish a new formula predicting liver metastasis in patients with colorectal cancer (CRC). METHODS:Nine previously reported predictive markers for liver metastasis and/or prognosis (COX-2, dysadherin, E-cadherin, beta-catenin, Ki-67, p53, laminin5gamma2, matrilysin and MUC...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000151667

    authors: Ochiai H,Nakanishi Y,Fukasawa Y,Sato Y,Yoshimura K,Moriya Y,Kanai Y,Watanabe M,Hasegawa H,Kitagawa Y,Kitajima M,Hirohashi S

    更新日期:2008-01-01 00:00:00

  • Histological staining by tritiated actinomycin D: a useful tool to study neoplastic cell heterogeneity and estrogen sensitivity of mammary tumors.

    abstract::The MXT mouse transplantable mammary cancer is characterized by significant amounts of steroid hormone receptors. Moreover this model, as other solid tumors, contains diverse subpopulations of neoplastic cells. In the present study we have examined this pattern as well as the influence of exogenous physiologic doses o...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226015

    authors: Kiss R,Leclercq G,Danguy A

    更新日期:1985-01-01 00:00:00

  • Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumours'.

    abstract::Coagulation disorders are frequently detected in patients affected by different tumours even though clinical symptoms occur in a very small percentage of such subjects. Coagulation processes are probably involved in the mechanism of metastatic spread. We assayed the plasma levels of thrombin-antithrombin III (TAT) com...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227086

    authors: Bartoloni C,Guidi L,Tricerri A,Patriarca F,Pili R,Cursi F,Canetta M,Cappelli A,Vangeli M,Salvati F

    更新日期:1992-01-01 00:00:00

  • Oxaliplatin-5-fluorouracil and ionizing radiation. Importance of the sequence and influence of p53 status.

    abstract:OBJECTIVES AND METHODS:The association oxaliplatin (OXA)-5-fluorouracil/folinic acid (FUFA) is currently a standard first-line treatment for advanced colorectal cancer. The main objective of this experimental study was to examine the cytotoxic effects resulting from the addition of ionizing radiation (Rgamma) to the co...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000069308

    authors: Magné N,Fischel JL,Formento P,Etienne MC,Dubreuil A,Marcié S,Lagrange JL,Milano G

    更新日期:2003-01-01 00:00:00

  • Droperidol as an antiemetic in cis-platinum-induced nausea and vomiting.

    abstract::23 patients received cis-platinum, doxorubicin and cyclophosphamide for gynecologic malignancy between December 1, 1980 and December 1, 1982. Each patient was randomized with each course of chemotherapy to receive intravenous droperidol or the combination of promethazine and chlorpromazine rectal suppositories as an a...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000225997

    authors: Roberts WS,Wisniewski BJ,Cavanagh D,Marsden DE

    更新日期:1985-01-01 00:00:00

  • Human Telomerase Reverse Transcriptase Gene Promoter Mutation in Serum of Patients with Hepatocellular Carcinoma.

    abstract:BACKGROUND:Mutations in the human telomerase reverse transcriptase (hTERT) gene promoter have been reported in hepatocellular carcinoma (HCC); however, analyses of these mutations in liquid biopsies have been technically difficult because of the high GC content of the regions of interest within this promoter. We evalua...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000506135

    authors: Ako S,Nouso K,Kinugasa H,Matsushita H,Terasawa H,Adachi T,Wada N,Takeuchi Y,Mandai M,Onishi H,Ikeda F,Shiraha H,Takaki A,Fujioka S,Mimura T,Okada H

    更新日期:2020-01-01 00:00:00

  • A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells.

    abstract:PURPOSE:In order to broaden the possibility for anti-MAGE-3 immune targeting, it is important to identify HLA-A24-restricted epitopes derived from MAGE-3, since HLA-A24 is one of the most common alleles in Japanese and Asian people. In the present study, we defined a new MAGE-3 derived, HLA-A24-binding peptide presente...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000091185

    authors: Miyagawa N,Kono K,Mimura K,Omata H,Sugai H,Fujii H

    更新日期:2006-01-01 00:00:00

  • Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging.

    abstract::Two randomized controlled trials identified that transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) shows a significant survival benefit compared with controls, after a long-term controversy. Thus, TACE is the current standard of care for patients presenting with multinodular HCC. Monit...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000345891

    authors: Minami Y,Kudo M

    更新日期:2013-01-01 00:00:00

  • Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.

    abstract:AIM:The aim of this study was to assess the molecular subtype profiles of male breast cancer (MBC) and subsequent clinical outcome using a validated 6-marker immunohistochemical panel. METHODS:A total of 43 cases of MBC were examined retrospectively using a semiquantitative immunohistochemical analysis of estrogen rec...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000341537

    authors: Sánchez-Muñoz A,Román-Jobacho A,Pérez-Villa L,Sánchez-Rovira P,Miramón J,Pérez D,Sáez MI,de Luque V,Medina L,Ramírez-Tortosa CL,Vicioso L,Medina JA,Ribelles N,Alba E

    更新日期:2012-01-01 00:00:00

  • Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels.

    abstract:OBJECTIVES:To examine the efficacy and prognostic benefits of radiotherapy (RT) in patients who have unresectable advanced hepatocellular carcinoma (HCC) with invasion to intrahepatic large vessels (IHLVs). METHODS:Sixty-eight patients who had advanced HCC with invasion to IHLVs were studied. Thirty-two consecutive pa...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000120996

    authors: Nakazawa T,Adachi S,Kitano M,Isobe Y,Kokubu S,Hidaka H,Ono K,Okuwaki Y,Watanabe M,Shibuya A,Saigenji K

    更新日期:2007-01-01 00:00:00

  • Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.

    abstract::This study sought to examine the relationship between MUC1 expression at the deepest invasive portion, invasive/metastatic potential, and prognosis of colorectal cancer in relation to cellular proliferation. MUC1 expression was detected immunohistochemically using KL-6 antibody (anti-MUC1 monoclonal antibody) in 100 s...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011868

    authors: Hiraga Y,Tanaka S,Haruma K,Yoshihara M,Sumii K,Kajiyama G,Shimamoto F,Kohno N

    更新日期:1998-07-01 00:00:00

  • Mitomycin therapy in gastric cancer.

    abstract::Adenocarcinoma of the stomach remains a significant cause of mortality worldwide. The majority of patients present with stage III or IV disease, negating surgery as a curative option. Numerous drugs have been tested over the past 2 decades in single-agent and combination chemotherapy trials. Given by intravenous bolus...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,评审

    doi:10.1159/000227249

    authors: Schnall S,Macdonald JS

    更新日期:1993-04-01 00:00:00

  • Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.

    abstract::The prognosis of brain glioblastoma is still very poor and the median survival time is generally less than 6 months. At present, no chemotherapy has appeared to influence its prognosis. On the other hand, recent advances in brain tumor biology have suggested that brain tumor growth is at least in part under a neuroend...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000227533

    authors: Lissoni P,Meregalli S,Nosetto L,Barni S,Tancini G,Fossati V,Maestroni G

    更新日期:1996-01-01 00:00:00

  • Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease.

    abstract::A patient seen at presentation for Hodgkin's disease (HD) at stage IV B was successfully treated with MOPP. In remission he developed coeliac disease, controlled by dietary measures, but 26 months after the end of chemotherapy a severe dyspeptic syndrome appeared; endoscopy and barium meal suggested the presence of a ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226345

    authors: Eridani S,Singh AK

    更新日期:1986-01-01 00:00:00

  • Protein accumulation in cultures of hepatic tumor cells exposed to dimethylsulfoxide.

    abstract::The effect of the differentiation-inducing agent dimethylsulfoxide (DMSO) on the protein composition of hepatic tumor cells was evaluated using the BW77-1 line of murine hepatoma cells previously determined to be DMSO-inducible for enhanced liver function. DMSO-mediated suppression of BW77-1 proliferation was accompan...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225850

    authors: Higgins PJ

    更新日期:1984-01-01 00:00:00

  • Hypoalbuminemia in patients receiving cisplatin: correlation between liver platinum and decrease in serum albumin.

    abstract::We evaluated changes in serum albumin concentrations in 15 patients with advanced malignancy who were also receiving cisplatin. All 15 patients had serial measurements of serum albumin. The decrease in serum albumin from the time of the first dose of cisplatin to death correlated with liver platinum levels at autopsy ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226100

    authors: Nanji AA,Mikhael NZ,Stewart DJ

    更新日期:1986-01-01 00:00:00

  • Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case report.

    abstract::Sorafenib, an oral multikinase inhibitor, has demonstrated clinical efficacy in patients with advanced hepatocellular carcinoma (HCC). However, in the SHARP trial (Sorafenib HCC Assessment Randomized Protocol trial) and the Asia-Pacific trial (conducted in the Asia-Pacific region), no cases of complete response (CR) w...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000333279

    authors: Inuzuka T,Nishikawa H,Sekikawa A,Takeda H,Henmi S,Sakamoto A,Saito S,Kita R,Kimura T,Osaki Y,Kudo M

    更新日期:2011-01-01 00:00:00

  • Progress in surgical treatment of hepatocellular carcinoma.

    abstract::Surgery for hepatocellular carcinoma has improved dramatically during the last two decades, and the improvement is mainly attributable to the development of intraoperative ultrasound-guided operative procedures such as Makuuchi's segmentectomy, introduction of the intermittent vascular occlusion technique, and establi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000048280

    authors: Makuuchi M,Imamura H,Sugawara Y,Takayama T

    更新日期:2002-01-01 00:00:00

  • Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers.

    abstract:OBJECTIVE:An increasing number of patients with advanced pancreatic or biliary tract cancer who progress after a gemcitabine-containing regimen are candidates for further chemotherapy. We therefore evaluated a fully oral regimen of capecitabine and celecoxib (CapCel) as second-line treatment in these patients. METHODS...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000205388

    authors: Pino MS,Milella M,Gelibter A,Sperduti I,De Marco S,Nuzzo C,Bria E,Carpanese L,Ruggeri EM,Carlini P,Cognetti F

    更新日期:2009-01-01 00:00:00

  • Perioperative Chemotherapy in Elderly Patients with Locally Advanced Adenocarcinoma of the Stomach and the Esophagogastric Junction: A Retrospective Cohort Analysis of Toxicity and Efficacy at the National Center for Tumor Diseases, Heidelberg.

    abstract:OBJECTIVE:Esophagogastric cancer occurs more frequently in older patients, but these are underrepresented in clinical studies establishing the current treatment standards for perioperative chemotherapy in locally advanced disease. This leads to uncertainty regarding the treatment of older patients with potentially toxi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000458531

    authors: Haag GM,Byl A,Jäger D,Berger AK

    更新日期:2017-01-01 00:00:00

  • Systemic chemotherapy of hepatocellular carcinoma--Korean experience.

    abstract::Surgical resection, transarterial chemoembolization, percutaneous ethanol injection therapy, radiofrequency ablation, and orthotopic liver transplantation are generally accepted treatment modalities in hepatocellular carcinoma, but there has been no standard therapy for patients at the advanced stage. Several combinat...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000173432

    authors: Lee HC

    更新日期:2008-01-01 00:00:00

  • Detection of High-Grade Pancreatic Intraepithelial Neoplasia without Morphological Changes of the Main Pancreatic Duct over a Long Period: Importance for Close Follow-Up for Confirmation.

    abstract::Pancreatic intraepithelial neoplasia (PanIN) is a microscopic papillary noninvasive lesion arising from the pancreatic ductal epithelium. However, the natural history and time to progression of high-grade PanIN remain unclear. Herein, we report 2 cases of high-grade PanIN without morphological changes of the main panc...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000481237

    authors: Yamao K,Takenaka M,Nakai A,Omoto S,Kamata K,Minaga K,Miyata T,Imai H,Sakurai T,Watanabe T,Nishida N,Matsumoto I,Takeyama Y,Chikugo T,Kudo M

    更新日期:2017-01-01 00:00:00

  • Biological effects of 5-azacytidine in eukaryotes.

    abstract::5-Azacytidine (NSC-102 816) was prepared synthetically and independently isolated from the culture filtrate of Streptoverticillium ladakanus. It is an s-triazine analogue of cytidine possessing a broad spectrum of biological effects. In mammalian tissueit is phosphorylated to 5-azacytidine 5-phosphates and incorporate...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000224981

    authors: Cihák A

    更新日期:1974-01-01 00:00:00

  • Role of estrogen and estrogen-related growth factor in the mechanism of hormone dependency of endometrial carcinoma cells.

    abstract::The role of estrogen and estrogen-related growth factors in the mechanism of hormone dependency of endometrial adenocarcinoma cells was investigated. The proliferation of hormone-responsive human endometrial adenocarcinoma cells (Ishikawa cells), which possess both estrogen and progesterone receptors, was optimally st...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000055257

    authors: Hata H,Hamano M,Watanabe J,Kuramoto H

    更新日期:1998-12-01 00:00:00

  • Quercetin inhibits the action of 12-O-tetradecanoylphorbol-13-acetate, a tumor promoter.

    abstract::Quercetin, a mutagenic but noncarcinogenic flavonoid, inhibited the increased incorporation of inorganic phosphate into phospholipids of human embryo fibroblasts induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), a potent tumor promoter. Quercetin also inhibited TPA-induced increases of sugar transport and RNA syn...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225805

    authors: Nishino H,Nishino A,Iwashima A,Tanaka K,Matsuura T

    更新日期:1984-01-01 00:00:00

  • Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic significance and treatment.

    abstract::As the antitumor activity of radiation is mediated via its interaction with oxygen to form labile free radicals, the intratumoral oxygen level has an important influence on the ability of radiation therapy to kill malignant cells. By decreasing the oxygen-carrying capacity of the blood, anemia may result in tumor hypo...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000067147

    authors: Harrison LB,Shasha D,Homel P

    更新日期:2002-01-01 00:00:00

  • Phase-I clinical trial of sodium cyanate in patients with advanced colorectal carcinoma.

    abstract::Sodium cyanate, a drug that selectively suppresses amino acid incorporation for protein synthesis in tumor tissue, was given to patients with advanced colorectal carcinoma who had failed to conventional therapy, with the purpose of assessing a maximum tolerable oral dose. At 35 mg/kg p.o. daily, the drug had to be sto...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226038

    authors: Herrera-Ornelas L,Petrelli NJ,Madajewicz S,Mittelman A,Allfrey VG

    更新日期:1985-01-01 00:00:00

  • Extrahepatic Hodgkin's disease with intrahepatic cholestasis: report of two cases.

    abstract::Liver is involved in about 5-8% of newly diagnosed Hodgkin's disease (HD) cases. The incidence reaches up to 50-60% in postmortem studies. In the literature only a few cases of idiopathic cholestatic jaundice have been described without an apparent cause and a paraneoplastic etiology has been suggested. We report 2 ca...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012005

    authors: Yalçin S,Kars A,Sökmensüer C,Atahan L

    更新日期:1999-07-01 00:00:00

  • A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer.

    abstract:OBJECTIVES:The purpose of this study was to evaluate the antitumor activity and safety of an epirubicin, cisplatin, and capecitabine (ECX) combination in patients with metastatic or advanced gastric cancer. PATIENTS AND METHODS:Patients with metastatic or advanced measurable gastric adenocarcinoma received ECX combina...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1159/000086972

    authors: Cho EK,Lee WK,Im SA,Lee SN,Park SH,Bang SM,Park DK,Park YH,Shin DB,Lee JH

    更新日期:2005-01-01 00:00:00